IPF-035

Idiopathic Pulmonary Fibrosis (IPF)

克利夫兰 55 years old male United States Total Cost: 258

Patient Condition

The patient was presented with progressive shortness of breath and dry cough, and had a history of smoking (15 pack-years). HRCT showed honeycomb lungs and grid shadows in both lungs. Lung function: FVC 58% predicted, DLCO 42% predicted. 6MWD 340m, mMRC score 2. IPF was diagnosed (GAP score of 4, stage II). Complicated with obstructive sleep apnea.

Treatment Timeline

PhaseDetailsDate
integrated assessment
Combination therapy initiated
Combination therapy + pulmonary rehabilitation (months 1-12)
Maintenance treatment (Months 13-24)

Treatment Outcome

beforeFVC accounted for 58% of predicted value, DLCO accounted for 42% of predicted value, 6MWD 340m, mMRC score 2, combined with OSA
afterAfter 24 months of treatment, FVC accounted for 54% of the predicted value (annual decline rate of approximately 2%), DLCO accounted for 38% of the predicted value, 6MWD 400m (improvement of 60m), and mMRC score dropped to level 1
highlightCombined treatment with Nitrib +NAC combined with CPAP and systemic lung rehabilitation improved 6MWD by 60 meters, mMRC score dropped from level 2 to level 1, and the effect of multidisciplinary comprehensive management was excellent.